An entrepreneurial masterclass! #Limflow @InariMedical @hendolat @VEITHsymposium @VascularSVS @LINCmeeting @vascularpodcast

The @VascularSVS #CPVI exceeded all expectations. Huge thanks to the faculty that made it possible for @CLI_LimFlow to participate 🙌

Fantastic discussion on the evolution of Entrepreneurship in the Vascular Space with Dr Peter Schneider, Dr Miguel Montero Baker, and Dr Lucas Ferrer. A super panel who bring a ton of insight and experience to the topic.

4 million+ people have the most severe form of artery disease that blocks blood flow to their feet – Chronic Limb-Threatening Ischemia (#CLTI) – which can lead to #amputation. We are fighting against limb loss. https://t.co/On9OEaWvRx

Listen to LimFlow CEO Dan Rose discuss the crisis of Chronic Limb-Threatening Ischemia (CLTI) and what FDA approval of the LimFlow System can mean to people who can step off the path to amputation to have their lives and limbs saved. https://t.co/pT8iqiPMkS #amputation #limflow

#ICYMI: @LimFlowUK achieved #FDA clearance. the FDA's decision makes LimFlow the 1st and ONLY FDA-approved #device for transcatheter arterialization of deep veins to treat patients with critical limb ischemia, a long under-served patient population: https://t.co/6LLwBuaNc4

Thanks to LINC for a fantastic meeting, and thank you to the TADV focused session presenters (Dr. Peter Schneider, Dr. Miguel Montero Baker, Dr. Roberto Ferraresi, Dr. Steven Kum, Dr Michael Lichtenberg, Dr. Arne Schwindt, Dr. Daniel van den Heuvel, and Dr. Symeon Lechareas)

We are truly blessed to work with great investigators like Dr Dan Clair and Dr Mehdi H. Shishehbor in our mission to improve outcomes for CLTI patients. We are just at the beginning of showing what this technology and procedure can do and the future is ve… https://t.co/r3qHeD0AqI

This is incredibly important work. Thanks Dr Foluso Fakorede for your leadership here!

Thanks again to Stephen Levin and the MedTech Strategist for the invitation to join the Reimbursement Panel at #innovationdublin23. It was a pleasure to learn from my fellow panelists Arjun Desai and Ronan Glynn and to have a chance to talk about our expe… https://t.co/rjohVMRwfo

A leg is amputated every 2 minutes in the U.S. and Europe, and 150,000 Americans lose a limb through amputation each year. Medical innovation can impact these numbers. We are proud to be doing our part with LimFlow technology. #vascular #vasculardisease #limblossawarenessmonth

Fascinating results from Promise II by @shishem et al. in @nejm describing a novel endovascular technique to treat #CLTI where arterial flow is connected to deep-venous segments (venous “arterialization”) in order to perfuse the distal limb! https://t.co/doQbC1Owwb

The PROMISE II results set the stage for a new era of CLTI care. We are very excited about continuing to work together with clinicians to make a difference.

Hear from the Primary Investigators of Promise II ! Dan Clair Mehdi H. Shishehbor LimFlow SA

The publication of the landmark PROMISE II trial in the New England Journal of Medicine is a great step forward for patients suffering from Chronic Limb Threatening Ischemia. We are honored to have worked with the incredible PROMIS… https://t.co/dqSgtBv6Hw

Congrats to the PROMISE II Investigators and the LimFlow team for this extraordinary publication!

Work hard. Play hard. Accomplish extraordinary things together. It’s a privilege to work alongside these folks. Thomas Engels Theo Mastrokostopoulos Sophie HUMBERT Zachary Woodson Jenny Gaffney Mike Mathias Paul Limmer LimFlow SA

Fantastic event and a pleasure to share our vision and progress at LimFlow SA. 2024 is going to be an incredible year! #LSIUSA23 #mdstart #medtechinnovator #clti #clifighters

Looking forward the MedTech Strategist Innovation summit in Dublin (April 26th) and to joining the panel on "Getting Paid for Innovative Technologies" with Stephen Levin and Arjun Desai. Thoughtful navigation of the reimbursement… https://t.co/BQfDxcHU7C

Less than a month to LSI 2023! Looking forward to presenting LimFlow SA and sharing our vision for transforming the care of CLTI patients. 2023 is going to be an incredible year! #LSIUSA23 #clti #medtech #medtechinnovator #vascular Sofinnova Partners Bpif… https://t.co/vSRgn1yH3V